Clinical trials
Recruiting Fallopian Tube Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| AbbVie | 1 |
| Avenzo Therapeutics, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Fore Biotherapeutics | 1 |
| K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 13 |
| Ovarian Neoplasms | 8 |
| Carcinoma, Ovarian Epithelial | 6 |
| Breast Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Glioma | 2 |
| Neoplasm Metastasis | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Astrocytoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.